Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionDavis R M Inc
Latest Disclosed Ownership1,747 shares
Latest Disclosed Value $ 266,858
Davis R M Inc ownership in NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 13, 2026 - Davis R M Inc filed a 13F-HR form disclosing ownership of 1,747 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $266,854 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 12, 2025 disclosing 0 shares of Novartis AG - Depositary Receipt (Common Stock). The current value of the position is $250,974 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 1,747 1,747 267 0.0047
2025-11-12 2025-09-30 13F Novartis AG ADR COM 66987V109 0 -1,956 -100.00 0 -100.00
2025-08-07 2025-06-30 13F Novartis AG ADR COM 66987V109 1,956 -173 -8.13 237 -0.42 0.0044
2025-05-08 2025-03-31 13F Novartis AG ADR COM 66987V109 2,129 -45 -2.07 237 12.32 0.0048
2025-02-07 2024-12-31 13F Novartis AG ADR COM 66987V109 2,174 65 3.08 212 -12.81 0.0041
2024-11-13 2024-09-30 13F Novartis AG ADR COM 66987V109 2,109 -90 -4.09 243 3.42 0.0047
2024-08-09 2024-06-30 13F Novartis AG ADR COM 66987V109 2,199 100 4.76 234 15.27 0.0048
2024-05-10 2024-03-31 13F Novartis AG ADR COM 66987V109 2,099 -250 -10.64 203 -14.35 0.0043
2024-02-09 2023-12-31 13F Novartis AG ADR COM 66987V109 2,349 250 11.91 237 0.0055
2023-11-14 2023-09-30 13F Novartis AG ADR COM 66987V109 2,099 2,099 0 0.0054
2023-08-10 2023-06-30 13F Novartis AG ADR COM 66987V109 0 -3,559 -100.00 0 0.0000
2023-05-01 2023-03-31 13F Novartis AG ADR COM 66987V109 3,559 0 0.00 0 0.0083
2023-02-14 2022-12-31 13F Novartis AG ADR COM 66987V109 3,559 -13 -0.36 0 -100.00 0.0087
2022-11-08 2022-09-30 13F Novartis AG ADR COM 66987V109 3,572 58 1.65 272 -8.42 0.0079
2022-08-08 2022-06-30 13F Novartis AG ADR COM 66987V109 3,514 0 0.00 297 -3.57 0.0083
2022-05-05 2022-03-31 13F Novartis AG ADR COM 66987V109 3,514 -500 -12.46 308 -12.25 0.0073
2022-02-08 2021-12-31 13F Novartis Ag ADR COM 66987V109 4,014 -701 -14.87 351 -9.07 0.0078
2021-11-08 2021-09-30 13F Novartis Ag ADR COM 66987V109 4,715 101 2.19 386 -8.31 0.0096
2021-08-12 2021-06-30 13F Novartis Ag ADR COM 66987V109 4,614 325 7.58 421 14.71 0.0106
2021-05-10 2021-03-31 13F Novartis Ag ADR COM 66987V109 4,289 -695 -13.94 367 -22.08 0.0101
2021-01-27 2020-12-31 13F Novartis Ag ADR COM 66987V109 4,984 2,241 81.70 471 97.07 0.0135
2020-12-01 2020-09-30 13F Novartis Ag ADR COM 66987V109 2,743 275 11.14 239 10.65 0.0078
2020-07-20 2020-06-30 13F Novartis Ag ADR COM 66987V109 2,468 2,468 216 0.0077
2020-04-24 2020-03-31 13F Novartis Ag ADR COM 66987V109 0 -2,374 -100.00 0 -100.00
2020-01-23 2019-12-31 13F Novartis Ag ADR COM 66987V109 2,374 -54 -2.22 225 6.64 0.0074
2019-10-24 2019-09-30 13F Novartis Ag ADR COM 66987V109 2,428 133 5.80 211 0.48 0.0074
2019-07-31 2019-06-30 13F Novartis Ag ADR COM 66987V109 2,295 0 0.00 210 -4.98 0.0075
2019-04-29 2019-03-31 13F Novartis Ag ADR COM 66987V109 2,295 -255 -10.00 221 0.91 0.0082
2019-01-18 2018-12-31 13F Novartis Ag ADR COM 66987V109 2,550 224 9.63 219 9.50 0.0090
2018-10-17 2018-09-30 13F Novartis Ag ADR COM 66987V109 2,326 2,326 200 0.0073
2018-07-19 2018-06-30 13F NOVARTIS AG ADR COM 66987V109 0 -2,625 -100.00 0 -100.00
2018-04-19 2018-03-31 13F NOVARTIS AG ADR COM 66987V109 2,625 100 3.96 212 0.00 0.0084
2018-01-16 2017-12-31 13F NOVARTIS AG ADR COM 66987V109 2,525 0 0.00 212 -2.30 0.0083
2017-10-24 2017-09-30 13F NOVARTIS AG ADR COM 66987V109 2,525 -63 -2.43 217 0.46 0.0090
2017-07-31 2017-06-30 13F NOVARTIS AG ADR COM 66987V109 2,588 2,588 216 0.0091
2017-05-03 2017-03-31 13F NOVARTIS AG ADR COM 66987V109 0 -3,380 -100.00 0 -100.00
2017-01-18 2016-12-31 13F NOVARTIS AG ADR COM 66987V109 3,380 500 17.36 246 8.37 0.0118
2016-10-19 2016-09-30 13F NOVARTIS AG ADR COM 66987V109 2,880 -505 -14.92 227 -18.64 0.0111
2016-07-14 2016-06-30 13F NOVARTIS AG ADR COM 66987V109 3,385 -280 -7.64 279 5.28 0.0137
2016-04-18 2016-03-31 13F NOVARTIS AG ADR COM 66987V109 3,665 -534 -12.72 265 -26.59 0.0135
2016-01-14 2015-12-31 13F NOVARTIS AG ADR COM 66987V109 4,199 -775 -15.58 361 -21.01 0.0185
2015-10-16 2015-09-30 13F NOVARTIS AG ADR COM 66987V109 4,974 654 15.14 457 7.53 0.0244
2015-07-16 2015-06-30 13F NOVARTIS AG ADR COM 66987V109 4,320 -106 -2.39 425 -2.52 0.0220
2015-04-17 2015-03-31 13F NOVARTIS AG ADR COM 66987V109 4,426 911 25.92 436 33.74 0.0229
2015-01-23 2014-12-31 13F NOVARTIS AG ADR COM 66987V109 3,515 545 18.35 326 16.43 0.0180
2014-10-20 2014-09-30 13F/A-2 NOVARTIS AG ADR COM 66987V109 2,970 -1,560 -34.44 280 -31.71 0.0161
2014-10-20 2014-09-30 13F/A-1 NOVARTIS AG ADR COM 66987V109 2,970 0 280 0.0161
2014-10-20 2014-09-30 13F NOVARTIS AG ADR COM 66987V109 4,530 410
2014-07-15 2014-06-30 13F NOVARTIS AG ADR COM 66987V109 4,530 839 22.73 410 30.57 0.0236
2014-04-15 2014-03-31 13F NOVARTIS AG ADR COM 66987V109 3,691 -164 -4.25 314 1.29 0.0191
2014-01-27 2013-12-31 13F NOVARTIS AG ADR COM 66987V109 3,855 -80 -2.03 310 2.65 0.0190
2013-10-23 2013-09-30 13F NOVARTIS AG ADR COM 66987V109 3,935 3,935 302 0.0204
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.